Comparison of DNA content in non-Hodgkin's lymphoma as measured by flow cytometry and cytogenetics

Helen L. Grierson, Terry N. Wooldridge, Michelle Hess, Leslee Wooldridge, Anne Ratashak, Martin Bast, James Olen Armitage, Dennis D. Weisenburger, Warren G. Sanger

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Specific cytogenetic changes such as t(14;18) and t(8;14) are associated with specific histologic subtypes of non-Hodgkin's lymphoma (NHL) and may predict disease outcome. Nonspecific cytogenetic changes include other structural rearrangements or numerical changes such as monosomies and trisomies, which may cause changes in total cellular DNA content. In many solid tumors, the presence of abnormal DNA content may be predictive of clinical behavior. NHL biopsies, however, contain normal (diploid) as well as abnormal cells, and DNA changes in the peridiploid range are detectable by cytogenetic analysis, but not consistently by flow cytometry. In the present study, we performed flow cytometric and cytogenetic analysis of DNA on biopsies from 129 patients with non-Hodgkin's lymphoma (NHL). Cytogenetic studies were successful on 88 (68%) of the samples. There was 55% concordance between flow cytometric and cytogenetic techniques in detecting aneuploid DNA content, with the majority of discrepancies occurring in the peridiploid range. We also detected six samples which were aneuploid by flow cytometry, but diploid by cytogenetics. We suggest that a reasonable approach to determine DNA content, as it relates to prediction of outcome in NHL, would be to combine data from both of these techniques and analyze the results in terms of ranges of DNA rather than by categorizing as diploid versus aneuploid.

Original languageEnglish (US)
Pages (from-to)124-128
Number of pages5
JournalCancer genetics and cytogenetics
Volume80
Issue number2
DOIs
StatePublished - Jan 1 1995

Fingerprint

Cytogenetics
Non-Hodgkin's Lymphoma
Flow Cytometry
DNA
Cytogenetic Analysis
Aneuploidy
Diploidy
Biopsy
Monosomy
Trisomy
Neoplasms

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cancer Research

Cite this

Grierson, H. L., Wooldridge, T. N., Hess, M., Wooldridge, L., Ratashak, A., Bast, M., ... Sanger, W. G. (1995). Comparison of DNA content in non-Hodgkin's lymphoma as measured by flow cytometry and cytogenetics. Cancer genetics and cytogenetics, 80(2), 124-128. https://doi.org/10.1016/0165-4608(94)00178-E

Comparison of DNA content in non-Hodgkin's lymphoma as measured by flow cytometry and cytogenetics. / Grierson, Helen L.; Wooldridge, Terry N.; Hess, Michelle; Wooldridge, Leslee; Ratashak, Anne; Bast, Martin; Armitage, James Olen; Weisenburger, Dennis D.; Sanger, Warren G.

In: Cancer genetics and cytogenetics, Vol. 80, No. 2, 01.01.1995, p. 124-128.

Research output: Contribution to journalArticle

Grierson, HL, Wooldridge, TN, Hess, M, Wooldridge, L, Ratashak, A, Bast, M, Armitage, JO, Weisenburger, DD & Sanger, WG 1995, 'Comparison of DNA content in non-Hodgkin's lymphoma as measured by flow cytometry and cytogenetics', Cancer genetics and cytogenetics, vol. 80, no. 2, pp. 124-128. https://doi.org/10.1016/0165-4608(94)00178-E
Grierson, Helen L. ; Wooldridge, Terry N. ; Hess, Michelle ; Wooldridge, Leslee ; Ratashak, Anne ; Bast, Martin ; Armitage, James Olen ; Weisenburger, Dennis D. ; Sanger, Warren G. / Comparison of DNA content in non-Hodgkin's lymphoma as measured by flow cytometry and cytogenetics. In: Cancer genetics and cytogenetics. 1995 ; Vol. 80, No. 2. pp. 124-128.
@article{137f2470767a47f592ad61197effc84f,
title = "Comparison of DNA content in non-Hodgkin's lymphoma as measured by flow cytometry and cytogenetics",
abstract = "Specific cytogenetic changes such as t(14;18) and t(8;14) are associated with specific histologic subtypes of non-Hodgkin's lymphoma (NHL) and may predict disease outcome. Nonspecific cytogenetic changes include other structural rearrangements or numerical changes such as monosomies and trisomies, which may cause changes in total cellular DNA content. In many solid tumors, the presence of abnormal DNA content may be predictive of clinical behavior. NHL biopsies, however, contain normal (diploid) as well as abnormal cells, and DNA changes in the peridiploid range are detectable by cytogenetic analysis, but not consistently by flow cytometry. In the present study, we performed flow cytometric and cytogenetic analysis of DNA on biopsies from 129 patients with non-Hodgkin's lymphoma (NHL). Cytogenetic studies were successful on 88 (68{\%}) of the samples. There was 55{\%} concordance between flow cytometric and cytogenetic techniques in detecting aneuploid DNA content, with the majority of discrepancies occurring in the peridiploid range. We also detected six samples which were aneuploid by flow cytometry, but diploid by cytogenetics. We suggest that a reasonable approach to determine DNA content, as it relates to prediction of outcome in NHL, would be to combine data from both of these techniques and analyze the results in terms of ranges of DNA rather than by categorizing as diploid versus aneuploid.",
author = "Grierson, {Helen L.} and Wooldridge, {Terry N.} and Michelle Hess and Leslee Wooldridge and Anne Ratashak and Martin Bast and Armitage, {James Olen} and Weisenburger, {Dennis D.} and Sanger, {Warren G.}",
year = "1995",
month = "1",
day = "1",
doi = "10.1016/0165-4608(94)00178-E",
language = "English (US)",
volume = "80",
pages = "124--128",
journal = "Cancer Genetics and Cytogenetics",
issn = "0165-4608",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Comparison of DNA content in non-Hodgkin's lymphoma as measured by flow cytometry and cytogenetics

AU - Grierson, Helen L.

AU - Wooldridge, Terry N.

AU - Hess, Michelle

AU - Wooldridge, Leslee

AU - Ratashak, Anne

AU - Bast, Martin

AU - Armitage, James Olen

AU - Weisenburger, Dennis D.

AU - Sanger, Warren G.

PY - 1995/1/1

Y1 - 1995/1/1

N2 - Specific cytogenetic changes such as t(14;18) and t(8;14) are associated with specific histologic subtypes of non-Hodgkin's lymphoma (NHL) and may predict disease outcome. Nonspecific cytogenetic changes include other structural rearrangements or numerical changes such as monosomies and trisomies, which may cause changes in total cellular DNA content. In many solid tumors, the presence of abnormal DNA content may be predictive of clinical behavior. NHL biopsies, however, contain normal (diploid) as well as abnormal cells, and DNA changes in the peridiploid range are detectable by cytogenetic analysis, but not consistently by flow cytometry. In the present study, we performed flow cytometric and cytogenetic analysis of DNA on biopsies from 129 patients with non-Hodgkin's lymphoma (NHL). Cytogenetic studies were successful on 88 (68%) of the samples. There was 55% concordance between flow cytometric and cytogenetic techniques in detecting aneuploid DNA content, with the majority of discrepancies occurring in the peridiploid range. We also detected six samples which were aneuploid by flow cytometry, but diploid by cytogenetics. We suggest that a reasonable approach to determine DNA content, as it relates to prediction of outcome in NHL, would be to combine data from both of these techniques and analyze the results in terms of ranges of DNA rather than by categorizing as diploid versus aneuploid.

AB - Specific cytogenetic changes such as t(14;18) and t(8;14) are associated with specific histologic subtypes of non-Hodgkin's lymphoma (NHL) and may predict disease outcome. Nonspecific cytogenetic changes include other structural rearrangements or numerical changes such as monosomies and trisomies, which may cause changes in total cellular DNA content. In many solid tumors, the presence of abnormal DNA content may be predictive of clinical behavior. NHL biopsies, however, contain normal (diploid) as well as abnormal cells, and DNA changes in the peridiploid range are detectable by cytogenetic analysis, but not consistently by flow cytometry. In the present study, we performed flow cytometric and cytogenetic analysis of DNA on biopsies from 129 patients with non-Hodgkin's lymphoma (NHL). Cytogenetic studies were successful on 88 (68%) of the samples. There was 55% concordance between flow cytometric and cytogenetic techniques in detecting aneuploid DNA content, with the majority of discrepancies occurring in the peridiploid range. We also detected six samples which were aneuploid by flow cytometry, but diploid by cytogenetics. We suggest that a reasonable approach to determine DNA content, as it relates to prediction of outcome in NHL, would be to combine data from both of these techniques and analyze the results in terms of ranges of DNA rather than by categorizing as diploid versus aneuploid.

UR - http://www.scopus.com/inward/record.url?scp=0029043138&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029043138&partnerID=8YFLogxK

U2 - 10.1016/0165-4608(94)00178-E

DO - 10.1016/0165-4608(94)00178-E

M3 - Article

VL - 80

SP - 124

EP - 128

JO - Cancer Genetics and Cytogenetics

JF - Cancer Genetics and Cytogenetics

SN - 0165-4608

IS - 2

ER -